Active Mass Torts in 2026: Complete List

Disclaimer: This article is informational only and does not constitute legal advice. Mass tort and class action eligibility, deadlines, and settlement procedures vary by jurisdiction and individual circumstances. For specific case evaluation, consult a qualified attorney licensed in your state. Any payout ranges mentioned reflect publicly disclosed settlement administrator data and do not guarantee individual outcomes.

The landscape of mass tort litigation in the United States remains highly active and complex, with numerous Multi-District Litigations (MDLs) and class actions progressing through various stages. As of 2026, consumers and affected parties are closely watching several significant cases that address alleged harms from defective products, pharmaceutical drugs, and environmental contamination. Understanding the status of these active mass torts is crucial for anyone seeking information about potential claims or the broader legal trends impacting consumer safety.

This guide provides a comprehensive overview of the major active mass torts expected to be in litigation or nearing settlement phases in 2026. Our aim is to offer a clear, informational resource, drawing on publicly available data from official sources like the U.S. District Courts (USDC) — JPML Multi-District Litigation, to help you navigate this intricate legal domain without offering specific legal advice.

Understanding Multi-District Litigation (MDL) in 2026

Multi-District Litigation (MDL) is a special federal legal procedure designed to streamline the litigation process when numerous lawsuits involving common questions of fact are filed in different federal districts. Rather than hearing each case individually, the Judicial Panel on Multi-District Litigation (JPML) centralizes these cases before a single federal judge for coordinated pretrial proceedings. This process helps conserve judicial resources, avoid duplicative discovery, and prevent inconsistent rulings across similar cases.

Unlike a class action, where a single lawsuit represents a large group of people with similar claims, an MDL involves individual lawsuits that are grouped for efficiency. While class actions typically result in a single settlement or verdict distributed among class members, MDLs often lead to individual settlements or trials if cases are remanded back to their original courts. For a deeper dive into these distinctions, you can explore our guide on Mass Tort vs Class Action: Key Differences.

The JPML docket for 2026 continues to reflect a dynamic environment, with new MDLs being formed and existing ones advancing. A Plaintiff Steering Committee (PSC), comprised of attorneys representing the plaintiffs, often takes the lead in discovery, motions, and negotiating potential global settlements. The ultimate goal of centralized litigation is to facilitate an efficient resolution for all parties, whether through settlement or individual trials, once the common legal and factual issues have been addressed.

Major Active Mass Torts to Watch in 2026

Several significant mass torts are anticipated to remain highly active throughout 2026, representing some of the biggest and most impactful cases for consumers. These litigations often involve complex scientific and medical evidence, and their outcomes can have far-reaching implications for product safety and corporate accountability. Here are some of the prominent MDLs currently pending in U.S. District Courts:

• Talcum Powder Lawsuits (MDL 2738): This long-running litigation continues to address allegations that talc-based products caused ovarian cancer and mesothelioma. As of 2026, cases are progressing through various stages, including ongoing settlement negotiations and individual trials. Eligibility for these lawsuits typically requires a diagnosis of ovarian cancer or mesothelioma and a history of talcum powder use. For more detailed information on who qualifies, consult our specific guide on Talcum Powder Lawsuit: Who Qualifies, and for those specifically affected by mesothelioma, our article on Talc-Related Mesothelioma Claims Explained.

• Paraquat Herbicide Lawsuits (MDL 3004): These cases allege that exposure to the herbicide Paraquat causes Parkinson’s disease. Litigation is centralized in the Southern District of Illinois, with bellwether trials expected to continue or conclude in 2026. Plaintiffs claim that manufacturers failed to adequately warn users about the severe neurological risks associated with the product.

• Hair Relaxer Cancer Lawsuits (MDL 3060): This relatively newer MDL focuses on claims that chemical hair relaxer products cause uterine cancer, ovarian cancer, and other reproductive health issues. As of 2026, discovery is ongoing, and the litigation is in its early stages of development, with a growing number of plaintiffs joining the centralized proceedings.

• Ozempic, Wegovy, and Rybelsus Lawsuits (MDL 3094): These cases, consolidated in the Eastern District of Pennsylvania, allege that GLP-1 receptor agonist drugs, used for diabetes and weight loss, cause severe gastroparesis (stomach paralysis) and other gastrointestinal injuries. The litigation is expected to see significant activity in 2026 as discovery progresses and a master complaint is developed.

• 3M Combat Arms Earplugs Lawsuits (MDL 2885): While many claims in this MDL have been resolved through a global settlement, some individual cases and appeals may still be active in 2026. This litigation involved allegations that defective earplugs supplied to the U.S. military caused hearing loss and tinnitus in service members. The settlement administrator is handling the distribution of funds to eligible claimants.

Navigating the Mass Tort Settlement Process in 2026

The path to resolution in a mass tort case can be lengthy and complex, often involving several distinct phases. After cases are centralized into an MDL, the process typically begins with extensive discovery, where both sides exchange information and evidence. This is followed by pretrial motions and, in many instances, bellwether trials.

Bellwether trials are test cases selected from the larger pool of claims. These trials are crucial because their outcomes can provide both sides with valuable insights into how juries might react to evidence and arguments, thereby influencing settlement negotiations for the remaining cases. If bellwether trials result in significant plaintiff verdicts, it often puts pressure on defendants to negotiate a global settlement.

Once a settlement is reached, a court-appointed settlement administrator, such as KCC (formerly known as Kinsella Media) or Epiq, is typically responsible for managing the claims process, verifying eligibility, and distributing funds to qualified plaintiffs. The duration of a typical mass tort case can vary significantly, ranging from a few years to more than a decade, depending on the complexity of the science, the number of plaintiffs, and the willingness of parties to negotiate. For a comprehensive understanding of the stages involved, refer to our Mass Tort Settlement Process: Complete Guide.

Here is an overview of select active mass torts and their general status as of 2026:

Key Settlement Figures for 2026

While specific settlement amounts for ongoing cases are often confidential until finalized, general trends and publicly announced figures from past or recently concluded mass torts can offer perspective. It is crucial to remember that individual payouts in mass tort settlements vary widely based on the specific facts of each case, the severity of injuries, and the jurisdiction. As of 2026, here are some general observations and projected figures:

• Average Settlement Ranges: Payouts can range from tens of thousands of dollars for less severe injuries to several hundred thousand or even millions of dollars for catastrophic injuries or wrongful death claims. These ranges are highly dependent on the particular tort and the established injury matrix within a settlement fund.

• Global Settlement Values: Major mass torts often involve global settlement funds reaching into the hundreds of millions or even billions of USD. For example, some large pharmaceutical or medical device MDLs have seen settlements exceeding $1 billion in total, distributed among eligible claimants over several years.

• Claimant Participation Rates: The number of eligible claimants who participate in a settlement can significantly impact individual payout amounts. Higher participation rates may lead to lower individual awards if the total settlement fund is fixed.

• Administrative Costs and Attorney Fees: A portion of any settlement fund is typically allocated to administrative costs for the settlement administrator and attorney fees, which are usually contingency-based and agreed upon by the plaintiff. These deductions are factored in before net distributions to claimants.

Eligibility and Claim Filing for Mass Tort Cases

Determining eligibility for a mass tort claim is a critical first step. Generally, eligibility depends on several factors, including: 1) experiencing a specific injury or adverse health effect, 2) having used a particular product or been exposed to a specific substance, and 3) the timing of both the exposure and the injury. For instance, in a product liability case, you would typically need to demonstrate that you used the product in question and subsequently suffered a documented injury directly linked to that product.

Given the complexity of these cases, eligibility depends on a thorough review by a qualified attorney. They can assess your individual circumstances, medical records, and product usage history against the criteria established in the master complaint or potential settlement agreements. It is highly recommended to consult a qualified attorney to understand your rights and potential eligibility. For further insights into the process, our guide on How Mass Tort Claims Work: Step-by-Step provides a detailed explanation.

Another crucial factor is the statute of limitations, which sets a deadline for filing a lawsuit. These deadlines vary significantly by state and by the type of claim. For example, in California, the general statute of limitations for personal injury is two years from the date of injury (California Code of Civil Procedure § 335.1), but specific circumstances can alter this. Missing the statute of limitations can permanently bar you from pursuing a claim, so it is imperative to act promptly if you believe you have a potential case.

What are the biggest mass tort lawsuits for 2026?

As of 2026, some of the most significant mass tort lawsuits, based on the number of plaintiffs and potential impact, include the Talcum Powder lawsuits, Paraquat Herbicide litigation, Hair Relaxer Cancer claims, and the emerging Ozempic, Wegovy, and Rybelsus lawsuits. These cases involve widespread allegations of serious injuries and are closely watched by consumers and the legal community.

How do I join an active mass tort litigation?

To join an active mass tort litigation, you typically need to consult with a qualified personal injury attorney. They will evaluate your potential claim, determine if you meet the eligibility criteria for the specific MDL, and guide you through the process of filing a lawsuit or submitting a claim to an existing settlement fund. You cannot directly “join” an MDL without legal representation.

Which MDLs are currently pending in U.S. District Courts?

A comprehensive list of all Multi-District Litigations currently pending in U.S. District Courts can be found on the official website of the U.S. District Courts (USDC) — JPML Multi-District Litigation. This resource provides detailed information on each MDL, including the presiding judge, the district court, and the general nature of the litigation.

What is the status of the JPML docket for 2026?

The JPML docket for 2026 remains highly active, with the panel regularly reviewing petitions to create new MDLs, transfer cases, and consider remands. The status of specific MDLs, including their progression through discovery, bellwether trials, or settlement phases, is continuously updated on the official JPML website. It serves as the primary source for current information on centralized litigation.

How long does a typical mass tort case take to settle?

The duration of a typical mass tort case can vary significantly, often ranging from three to ten years or even longer. Factors influencing this timeline include the complexity of the scientific evidence, the number of plaintiffs involved, the willingness of the parties to engage in settlement negotiations, and the court’s schedule. Cases involving extensive discovery or multiple bellwether trials tend to take longer to reach a resolution.

The landscape of active mass torts in 2026 underscores the ongoing efforts to hold manufacturers and corporations accountable for alleged harms. For individuals who believe they may have been affected by a defective product or negligent action, staying informed is vital. While this article provides a general overview, specific legal guidance is essential. We encourage you to consult with a qualified attorney to discuss your unique situation. Additionally, official settlement administrator portals, such as those managed by KCC or Epiq, can provide direct information regarding specific settlement claim processes once they are established.

For assistance in finding a qualified legal professional, resources like the American Bar Association (ABA) Lawyer Referral Service or your state bar association can connect you with attorneys specializing in personal injury and mass tort litigation.

Need to find a qualified attorney? The ABA Lawyer Referral Service Directory provides state-by-state directories of certified lawyer referral services. State bar associations also maintain attorney verification tools. Avoid claims aggregators and choose attorneys with documented mass tort experience.

This article is informational only and does not constitute legal advice. Statute of limitations, eligibility, and settlement amounts vary by case specifics and jurisdiction. Last updated: June 2026.